Takeshi Ebihara

861 total citations
43 papers, 603 citations indexed

About

Takeshi Ebihara is a scholar working on Mechanical Engineering, Materials Chemistry and Epidemiology. According to data from OpenAlex, Takeshi Ebihara has authored 43 papers receiving a total of 603 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Mechanical Engineering, 11 papers in Materials Chemistry and 9 papers in Epidemiology. Recurrent topics in Takeshi Ebihara's work include Catalysis and Hydrodesulfurization Studies (11 papers), Catalytic Processes in Materials Science (9 papers) and GDF15 and Related Biomarkers (4 papers). Takeshi Ebihara is often cited by papers focused on Catalysis and Hydrodesulfurization Studies (11 papers), Catalytic Processes in Materials Science (9 papers) and GDF15 and Related Biomarkers (4 papers). Takeshi Ebihara collaborates with scholars based in Japan and United States. Takeshi Ebihara's co-authors include Takashi Fujikawa, Takeshi Kubota, Yasuaki Okamoto, Hiroshi Ogura, Hiroshi Matsuura, Chin‐Yu Lin, Makoto Senoo, Naoki Agata, Yasuyoshi Ueki and Yasunori Saheki and has published in prestigious journals such as Cell, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

Takeshi Ebihara

40 papers receiving 590 citations

Peers

Countries citing papers authored by Takeshi Ebihara

Since Specialization

Citations

This map shows the geographic impact of Takeshi Ebihara's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Takeshi Ebihara with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Takeshi Ebihara more than expected).

Fields of papers citing papers by Takeshi Ebihara

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Takeshi Ebihara. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Takeshi Ebihara. The network helps show where Takeshi Ebihara may publish in the future.

Co-authorship network of co-authors of Takeshi Ebihara

This figure shows the co-authorship network connecting the top 25 collaborators of Takeshi Ebihara. A scholar is included among the top collaborators of Takeshi Ebihara based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Takeshi Ebihara. Takeshi Ebihara is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Relationship between growth differentiation factor 15 and functional prognosis and severity in traumatic brain injury 2025 ·Scientific Reports ·H. Ito, Takeshi Ebihara, Hisatake Matsumoto, Jun Oda	1
2	Human precursor T follicular regulatory cells are primed for differentiation into mature Tfr and disrupted during severe infections 2025 ·Science Advances ·(unknown), Jonas Nørskov Søndergaard, David G. Priest, Takeshi Ebihara, Hisatake Matsumoto, Mara Anaís Llamas-Covarrubias, (unknown), Shinichi Esaki, Shinichi Iwasaki, Akimichi Morita, Sayuri Yamazaki, Shimon Sakaguchi, James B. Wing	0
3	Soluble T-Cadherin: A Novel Biomarker for Fluid Resuscitation in Burn Patients—A Single-Center Retrospective Observational Study 2025 ·Shock ·Kazuhiro Yoneda, Takeshi Ebihara, Shiro Fukuda, Shunbun Kita, Shinya Onishi, Hiroshi Matsuura, Akinori Osuka, Hitoshi Nishizawa, Iichiro Shimomura, Jun Oda	0
4	Atypical and non-classical CD45RBlo memory B cells are the majority of circulating SARS-CoV-2 specific B cells following mRNA vaccination or COVID-19 2024 ·Nature Communications ·David G. Priest, Takeshi Ebihara, (unknown), Jonas Nørskov Søndergaard, Shuhei Sakakibara, Fuminori Sugihara, Shunichiro Nakao, (unknown), Jumpei Yoshimura, Hiroshi Itô, Shinya Onishi, (unknown), Yumi Mitsuyama, Hiroshi Ogura, Jun Oda, (unknown), Hisatake Matsumoto, James B. Wing	6
5	Soluble T-cadherin secretion from endothelial cells is regulated via insulin/PI3K/Akt signalling 2024 ·Biochemical and Biophysical Research Communications ·(unknown), Shunbun Kita, Shiro Fukuda, (unknown), (unknown), (unknown), (unknown), (unknown), Hirofumi Nagao, Yoshinari Obata, Yuya Fujishima, Takeshi Ebihara, Hisatake Matsumoto, Satoshi Nakagawa, Tadashi Kimura, Hitoshi Nishizawa, Iichiro Shimomura	2
6	Classification of patients with COVID-19 by blood RNA endotype: a prospective cohort study 2023 ·Microbiology Spectrum ·Jumpei Yoshimura, (unknown), Takeshi Ebihara, Hisatake Matsumoto, Yumi Mitsuyama, Fuminori Sugihara, Haruhiko Hirata, Daisuke Okuzaki, Hiroshi Ogura	1
7	Combination of HBA1, TTR, and SERPINF2 in plasma defines phenotype correlated with severe burn outcome 2023 ·iScience ·Shinya Onishi, Hisatake Matsumoto, Fuminori Sugihara, Takeshi Ebihara, Hiroshi Matsuura, Akinori Osuka, Daisuke Okuzaki, Hiroshi Ogura, Jun Oda	4
8	Association between high cardiac output at altitude and acute mountain sickness: preliminary study on Mt. Fuji 2023 ·Journal of PHYSIOLOGICAL ANTHROPOLOGY ·Takeshi Ebihara, Kentaro K. Shimizu, Yumi Mitsuyama, Hiroshi Ogura, Jun Oda	4
9	Significance of interferon signaling based on mRNA-microRNA integration and plasma protein analyses in critically ill COVID-19 patients 2022 ·Molecular Therapy — Nucleic Acids ·(unknown), Hisatake Matsumoto, Jumpei Yoshimura, Tsunehiro Matsubara, Takeshi Ebihara, Hiroshi Matsuura, Yumi Mitsuyama, Takashi Kojima, Masakazu Ishikawa, Fuminori Sugihara, Haruhiko Hirata, Daisuke Okuzaki, Hiroshi Ogura	13
10	Combination of WFDC2, CHI3L1, and KRT19 in Plasma Defines a Clinically Useful Molecular Phenotype Associated with Prognosis in Critically Ill COVID-19 Patients 2022 ·Journal of Clinical Immunology ·Takeshi Ebihara, Tsunehiro Matsubara, (unknown), Hisatake Matsumoto, (unknown), Hiroshi Matsuura, Takashi Kojima, Fuminori Sugihara, Shigeto Seno, Daisuke Okuzaki, Haruhiko Hirata, Hiroshi Ogura	10
11	Resistin Associated With Cytokines and Endothelial Cell Adhesion Molecules Is Related to Worse Outcome in COVID-19 2022 ·Frontiers in Immunology ·Takeshi Ebihara, Hisatake Matsumoto, Tsunehiro Matsubara, (unknown), Shunichiro Nakao, Hiroshi Matsuura, Shinya Onishi, Takashi Kojima, Fuminori Sugihara, Daisuke Okuzaki, Haruhiko Hirata, Hitoshi Yamamura, Hiroshi Ogura	19
12	Cytokine Elevation in Severe COVID-19 From Longitudinal Proteomics Analysis: Comparison With Sepsis 2022 ·Frontiers in Immunology ·Takeshi Ebihara, Hisatake Matsumoto, Tsunehiro Matsubara, (unknown), Shunichiro Nakao, Hiroshi Matsuura, Takashi Kojima, Fuminori Sugihara, Daisuke Okuzaki, Haruhiko Hirata, Hitoshi Yamamura, Hiroshi Ogura	24
13	Resistin forms a network with inflammatory cytokines and is associated with prognosis in major burns 2021 ·Burns ·Shinya Onishi, Hiroshi Matsuura, Akinori Osuka, Hisatake Matsumoto, Takeshi Ebihara, Hiroshi Ogura	6
14	Hydrogen Gas Therapy Attenuates Inflammatory Pathway Signaling in Septic Mice 2021 ·Journal of Surgical Research ·Hiroshi Matsuura, Hisatake Matsumoto, Daisuke Okuzaki, Kentaro Shimizu, Hiroshi Ogura, Takeshi Ebihara, Tsunehiro Matsubara, Shin‐ichi Hirano, Takeshi Shimazu	7
15	Bone marrow-derived mononuclear cell therapy can attenuate systemic inflammation in rat heatstroke 2018 ·Scandinavian Journal of Trauma Resuscitation and Emergency Medicine ·Yutaka Umemura, Hiroshi Ogura, Hiroshi Matsuura, Takeshi Ebihara, Kentaro Shimizu, Takeshi Shimazu	19
16	Surveillance on The Safety and Efficacy of Ambrisentan (Volibris Tablet 2.5 mg) in Patients with Pulmonary Arterial Hypertension in Real Clinical Practice: Post-marketing Surveillance (Interim Analysis Report) 2017 ·Clinical Drug Investigation ·Tomohiko Takahashi, (unknown), Akihiro Kobayashi, (unknown), Takeshi Ebihara, (unknown)	5
17	Efficacy of isoproterenol for treating amlodipine overdose resulting in bradycardia 2017 ·Acute Medicine & Surgery ·Takeshi Ebihara, Masanori Morita, Masahiro Kawada, Koji Amano, (unknown), Yasuki Nakata	6
18	[Damage Control Surgery for Perforation of Colon Cancer]. 2016 ·PubMed ·Takeshi Ebihara, Motohiko Yamada, (unknown), Koji Amano, Masahiro Kawada, Genta Sawada, (unknown), Ken Nakata, Akihiro Usui, (unknown), Yutaka Kimura, Satoru Munakata, Yasuki Nakata, Junya Fujita	1
19	Application of ^ Xe NMR Spectroscopy to Analysis of Co-Mo/Al_2O_3 Hydrodesulfurization Catalyst : Effect of Sulfidation on ^ Xe NMR Spectra 2007 ·Bulletin of The Japan Petroleum Institute ·(unknown), Takeshi Ebihara, (unknown), Takashi Fujikawa	1
20	Increased Myeloid Cell Responses to M-CSF and RANKL Cause Bone Loss and Inflammation in SH3BP2 “Cherubism” Mice 2007 ·Cell ·Yasuyoshi Ueki, Chin‐Yu Lin, Makoto Senoo, Takeshi Ebihara, Naoki Agata, Masahiro Onji, Yasunori Saheki, Toshihisa Kawai, (unknown), Ernst Reichenberger, Bjørn R. Olsen	137

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact